Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus.
Torres T, Brembilla NC, Langley RG, Warren RB, Thaçi D, Kolios AGA, Prinz JC, Londono-Garcia A, Nast A, Santin M, Goletti D, Abreu M, Spuls P, Boehncke WH, Puig L. Torres T, et al. Among authors: nast a. J Eur Acad Dermatol Venereol. 2024 Aug 16. doi: 10.1111/jdv.20287. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39149807 Review.
[S3-Guidelines for the therapy of psoriasis vulgaris].
Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B; Germany Society for Dermatology. Nast A, et al. J Dtsch Dermatol Ges. 2006 Nov;4 Suppl 2:S1-126. doi: 10.1111/j.1610-0387.2006.06172.x. J Dtsch Dermatol Ges. 2006. PMID: 17187649 German. No abstract available.
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
Nast A, Kopp I, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. Nast A, et al. Arch Dermatol Res. 2007 Jun;299(3):111-38. doi: 10.1007/s00403-007-0744-y. Epub 2007 May 12. Arch Dermatol Res. 2007. PMID: 17497162 Free PMC article. Review.
Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. ...The short version of the guidelines reported here consist of a series of therapeutic recommenda …
Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of l …
Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris.
Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B; Deutsche Dermatologische Gesellschaft (DDG); Berufsverband Deutscher Dermatologen (BVDD). Nast A, et al. J Dtsch Dermatol Ges. 2007 Jul;5 Suppl 3:1-119. doi: 10.1111/j.1610-0387.2007.06172.x. J Dtsch Dermatol Ges. 2007. PMID: 17615051
European S3-guidelines on the systemic treatment of psoriasis vulgaris.
Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B. Pathirana D, et al. Among authors: nast a. J Eur Acad Dermatol Venereol. 2009 Oct;23 Suppl 2:1-70. doi: 10.1111/j.1468-3083.2009.03389.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19712190
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
Barker J, Horn EJ, Lebwohl M, Warren RB, Nast A, Rosenberg W, Smith C; International Psoriasis Council. Barker J, et al. Among authors: nast a. J Eur Acad Dermatol Venereol. 2011 Jul;25(7):758-64. doi: 10.1111/j.1468-3083.2010.03932.x. Epub 2010 Dec 29. J Eur Acad Dermatol Venereol. 2011. PMID: 21198946 Review.
[S3-guidelines for the treatment of psoriasis vulgaris Update 2011].
Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Müller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. Nast A, et al. J Dtsch Dermatol Ges. 2011 Jun;9 Suppl 2:S1-104. doi: 10.1111/j.1610-0379.2011.07680.x. J Dtsch Dermatol Ges. 2011. PMID: 21627770 German. No abstract available.
284 results